HomeAI · summaries
Storia in 20 fonti
Eli Lilly diz que novo medicamento ajuda pacientes com obesidade a perder 28% do peso corporal
Resultados do Retatrutida ao longo de um ano e meio, em um estudo, abrem caminho para que a empresa busque aprovação regulatória e lance o medicamento no próximo ano
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Retatrutide induces ‘impressive’ weight loss of up to 28.3% for adults with obesity
A once-weekly triple receptor agonist conferred up to 28.3% weight loss at 80 weeks for adults with overweight or obesity, according to topline results from a phase 3 trial. As…
- ·
nbcnews.com
People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says
The results — the most weight loss ever seen in a medication trial — put the drug’s effectiveness on par with bariatric surgery.
